IMRS News Alert Imris Inc (IMRS) 0.23 12/13/2014 06:29:02

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Imris Inc (IMRS) 0.23 $IMRS

Micro Market Monitor: Global Hyperspectral Imaging Market
M2 - Fri Dec 12, 4:08AM CST
Research and Markets (http://www.researchandmarkets.com/research/kdmfrn/micro_market) has announced the addition of the "Micro Market Monitor: Global Hyperspectral Imaging Market" report to their offering. In this report, the global intraoperative imaging market is broadly classified on the basis of product types. The products segment is classified into intraoperative MRI, intraoperative CT, and intraoperative ultrasound. Furthermore, based on type, the intraoperative CT market has been segmented further into mobile intraoperative CT, fully intraoperative suites, and O-arms and similar products. Geographically, the market is divided into four major regions, namely North America, Europe, Asia-Pacific, and Rest of the World (RoW). North America holds a major share in the global intraoperative imaging market, having accounted for 63.6% of the market in 2013, followed by Europe. The growth of the North American market is expected to be driven by factors such as the increasing government investments, research activities, and growing number of collaborations between various players in the market. The report has profiled the leading players of this market along with the developments (new product launches, partnerships, agreements, collaborations, and joint ventures) done by the companies over the past few years, and the strategies adopted by them to sustain and strengthen their position in the global intraoperative imaging market. BrainLAB AG (Germany), IMRIS Inc. (U.S.), Imaging3 Inc., (U.S.), Medtronic Inc., (U.S.), Neurologica Corporation (U.S.), and Siemens Healthcare (U.S.) are some of the key players engaged in this market. Key Topics Covered: 1 Hyperspectral Imaging Market, By Application 2 Hyperspectral Imaging Market, By Application 3 Global Hyperspectral Imaging Market, By Geography 4 Competitive Landscape Companies Mentioned - Applied Spectral Imaging Ltd. (U.S.) - Brandywine Photonics LLC (U.S.) - ChemImage Corp. (U.S.) - Cubert-GmbH (Germany) - CytoViva - FluxData - Galileo Group - GeoMetWatch Corp. (U.S.) - Gilden Photonics Ltd. (U.K.) - Gooch & Housego (U.K.) - Headwall Photonics Inc. (U.S.) - HyVista Corporation Pty Ltd (Australia) - IMEC (Belgium) - ITRES (Canada) - Inc. (U.S.) - Inno-spec GmbH (Germany) - LemnaTec GmbH (Germany) - Merrick & Company (U.S.) - MicaSense - Middleton Research (U.S.) - Raytheon ELCAN optical technologies (Canada) - Resonon - SPECIM (Finland) - Scientific Aerial Imaging - SpecTIR (U.S.) - Surface Optics Corp. (U.S.) - Teledyne DALSA Inc. (Canada) - VK DI Kerschhaggl GmbH (Germany) - Telops (Canada) For more information visit http://www.researchandmarkets.com/research/kd...cro_market About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
MDT: 72.52 (-1.25), RTN: 104.26 (-2.13), IMRS: 0.23 (-0.01)

5 Under-$10 Stocks Setting Up to Trade Higher: Must-See Charts
at The Street - Fri Dec 05, 10:21AM CST
Traders savvy enough to follow the low-priced names and trade them with discipline and sound risk management are banking ridiculous coin on a regular basis.
CRNT: 1.10 (-0.01), AMKR: 6.31 (-0.14), IMRS: 0.23 (-0.01), NTLS: 3.91 (+0.01), BSDM: 0.38 (unch)

IMRIS completes SYMBIS Surgical System human factors study
PR Newswire - Mon Dec 01, 5:12AM CST
18 US neurosurgeons from 9 leading institutions validate robot usability for final 510(k) submission deliverable
IMRS: 0.23 (-0.01), IM.TO: 0.26 (-0.02)

IMRIS CEO Jay D. Miller to present at the Canaccord Genuity Medical Technologies & Diagnostics Forum
PR Newswire - Mon Nov 17, 3:53PM CST
IMRIS Inc. (NASDAQ: IMRS; TSX: IM) will present at the Canaccord Genuity 2014 Medical Technologies & Diagnostics Forum at the Westin Grand Central, New York at 8:40 a.m. Eastern Time on Thursday, November 20, 2014.
IMRS: 0.23 (-0.01), IM.TO: 0.26 (-0.02)

Nasdaq stocks posting largest volume increases
AP - Fri Oct 31, 5:04PM CDT
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
ONCY: 0.61 (+0.03), IMRS: 0.23 (-0.01), IM.TO: 0.26 (-0.02), FCCO: 11.19 (-0.10), RDI: 12.59 (unch), CDTI: 1.91 (-0.09), ONC.TO: 0.71 (+0.08), DAIO: 3.35 (-0.14), AEGR: 21.09 (-0.22), RDIB: 12.88 (+0.52)

IMRIS neurosurgical suite opens at Boca Raton Regional Hospital
CNW Group - Wed Oct 29, 7:00AM CDT
Marcus Neuroscience Institute becomes first in Florida with both VISIUS iMRI and iCT for intraoperative imaging without patient transport
IMRS: 0.23 (-0.01), IM.TO: 0.26 (-0.02)

Imris affirms guidance after Q3 reults
Seeking Alpha - at Seeking Alpha - Tue Oct 28, 2:37PM CDT

IMRS: 0.23 (-0.01)

IMRIS' (IMRS) CEO Jay Miller on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Tue Oct 28, 1:01PM CDT

IMRS: 0.23 (-0.01)

Imris misses by $0.06, misses on revenue
Seeking Alpha - at Seeking Alpha - Tue Oct 28, 7:06AM CDT

IMRS: 0.23 (-0.01)

IMRIS Reports Third-Quarter 2014 Financial Results
CNW Group - Tue Oct 28, 7:01AM CDT
IMRIS Inc. (NASDAQ: IMRS; TSX: IM) today reported financial results for the 2014 third quarter ended September 30, 2014. All figures are reported in U.S. dollars. The Company's net loss in the 2014 third quarter was $8.4 million, or $0.16 per diluted share, on net revenues of $6.9 million. In the prior-year quarter, IMRIS reported a net loss of $3.8 million, or $0.07 per diluted share, on net revenues of $17.8 million. New order bookings were $6.1 million in the third quarter resulting in a backlog of $127.2 million.
IMRS: 0.23 (-0.01), IM.TO: 0.26 (-0.02)

IMRIS to Hold Third Quarter 2014 Financial Results Conference Call
CNW Group - Wed Oct 22, 3:47PM CDT
IMRIS Inc. (NASDAQ: IMRS; TSX: IM)
IMRS: 0.23 (-0.01), IM.TO: 0.26 (-0.02)

IMRIS intraoperative imaging solutions provide optimized visualization platform for emerging neurosurgical therapies
CNW Group - Thu Oct 09, 7:24AM CDT
Learn more about these state-of-the-art products at CNS annual meeting
IMRS: 0.23 (-0.01), IM.TO: 0.26 (-0.02)

IMRIS Horseshoe headrest named Life Sciences Alley New Technology Showcase winner
PR Newswire - Tue Sep 30, 7:00AM CDT
Intraoperative neurosurgical imaging solutions from IMRIS among featured medical technologies at upcoming November conference in Minneapolis
IMRS: 0.23 (-0.01), IM.TO: 0.26 (-0.02)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ampace Focuses on Battery Safety Standards at RE+ 2026

Updated Category News Views 20

Battery Safety Takes Center Stage No mystery here: the safety of our beloved lithium-ion batteries is crucial, especially as AI data centers sprout like weeds. At RE+ 2026, Ampace is putting its chips on the table by spotlighting this hot topic. Dr. Drew Feng, their Chief Safety Officer, is set to reveal the big guns: findings from the PU100 large-scale fire test. Mark...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 314

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
Midea's R290 Tech: Real Green Cooling Revolution?

Updated Category News Views 23

A Fresh Breeze in Sustainable Cooling In the middle of Kigali’s innovation oasis, Midea RAC stood out at MOP38, the 38th Meeting of the Parties to the Montreal Protocol, flexing its sustainable tech muscles. We're talking about their R290 air conditioning technology—a natural refrigerant with zero ozone footprint and a global warming potential of a mere three. This is...

Continue Reading
CureGene's CG-0416: Promising Weight Loss Breakthrough

Updated Category News Views 13

Game-Changer in Weight Management? Oh, the obesity world is buzzing, folks! There's some big noise coming from CureGene, and it's catching the attention of every lab-coat smarty in town. They just tossed out some preclinical data on CG-0416 at Obesity Week 2026 that could shake up how we tackle weight loss. Anyone still clinging to their old diet books might want to take...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 431

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 421

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
KINGRVER Boosts RV Comfort with New Water Heater Lineup

Updated Category News Views 328

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

Continue Reading
Sungrow's Keeper Family: Revolutionizing C&I Energy Storage

Updated Category News Views 12

The Next Level in Energy Storage Solutions Well, folks, Sungrow's got something up its sleeve that's shaking up the energy storage scene. They're calling it the 'Keeper Family,' and if you’re deep into commercial and industrial (C&I) energy storage, this might just be your ticket to topping those profit charts. Launched at the Global Energy Pioneer Summit 2026, their...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 286

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

Updated Category News Views 287

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

Continue Reading

Top 5 Most Recently Viewed Articles

AAVantgarde's Professor Auricchio Receives Prestigious Role

Updated Category News Views 177

AAVantgarde's Professor Auricchio Achieves New Milestone MILAN, a milestone moment has arrived for AAVantgarde Bio as Professor Alberto Auricchio, the visionary Founder and Chief Scientific Officer, has been elected President of the European Society of Gene and Cell Therapy. This prestigious appointment recognizes his exceptional contributions and unwavering commitment to...

Continue Reading
How Bitcoin's Drop Affects Strategy Inc (NASDAQ: MSTR) Investors

Updated Category News Views 137

Understanding the Current Market Landscape As recent market trends demonstrate, Strategy Inc (NASDAQ: MSTR) is seeing significant activity. On one hand, the company is evidently reliant on the performance of Bitcoin. With such dependence, the fluctuations in the value of Bitcoin are crucial to the health of MSTR. This situation poses both risks and opportunities for...

Continue Reading
Significant Attorney Departures to Strengthen Association Law Firm

Updated Category News Views 99

Major Attorney Moves to Association Law Group (ALG) In a noteworthy shift within Florida's community association law landscape, several prominent attorneys have transitioned from Becker & Poliakoff to join the ranks of Association Law Group (ALG). Among them, Michael C. Gongora, Lilliana Farinas-Sabogal, and Adam Cervera are recognized for their extensive experience in...

Continue Reading
EQB's Commitment to Sustainability in Financial Services

Updated Category News Views 175

EQB Focuses on Sustainability in Its Latest Report EQB Inc. (TSX: EQB) has recently published a detailed Responsibility Report, highlighting significant strides towards its sustainability commitments. This annual report encapsulates the company's dedication to fostering an environment of innovation within the Canadian banking sector, with a particular focus on enriching...

Continue Reading
BofA's Downgrade of Sandvik: Navigating Market Pressures Ahead

Updated Category News Views 103

BofA Securities dropped a bomb on Sandvik AB back then by downgrading it from Neutral to Underperform. This move sent shockwaves through the trading floor, mainly because they saw some serious trouble brewing in Sandvik’s Machining and Manufacturing Solutions (SMMS) division. Traders were quick to pick up on the whispers about short cycle pressures that could really...

Continue Reading